ADARx Pharmaceuticals, Inc. (ADRX) vs Precigen, Inc. (PGEN)

ADARx Pharmaceuticals, Inc. ADRX 13.20 −0.68%
Precigen, Inc. PGEN 4.43 +4.98%

ADARx Pharmaceuticals, Inc. and Precigen, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Precigen, Inc. are of similar size ($1.5B and $1.5B).

Metric	ADRX	PGEN	Biotechnology median
P/E	—	60.27	10.60
P/S	—	10.11	9.40
P/B	—	18.94	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	43.41	0.66
EV/Sales	—	10.51	9.02
Earnings yield	—	1.66%	(32.88%)
Free cash flow yield	—	(4.68%)	(23.13%)

Metric	ADRX	PGEN	Biotechnology median
Gross margin	—	91.42%	68.51%
Operating margin	—	21.43%	0.00%
Net margin	—	15.55%	0.00%
Free cash flow margin	—	(47.35%)	0.00%
Return on equity	—	38.84%	(51.96%)
Return on assets	—	12.73%	(46.06%)
Return on invested capital	—	15.93%	0.00%

Metric	ADRX	PGEN	Biotechnology median
Revenue growth (TTM)	—	2,387.61%	6.76%
EPS growth (last fiscal year)	—	(191.49%)	29.88%
Revenue growth, 5-year CAGR	—	(21.26%)	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	PGEN	Biotechnology median
Debt to equity	—	1.12	0.00
Current ratio	—	5.58	4.97
Net debt to EBITDA	—	0.04	1.01

Metric	ADRX	PGEN	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ADRX	PGEN	Biotechnology median
Market cap	1.47b	1.51b	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack